ORAL CANNABINOID FORMULATION COMPRISING TOCOPHERYL PHOSPHATES AND LONG CHAIN TRIGLYCERIDES OR LONG CHAIN FATTY ACIDS

摘要

The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.